a) The A/I ratio vs. the immune phenotype for the Mariathasan dataset, separated by gender. P-values are for comparisons between inflamed vs. desert and inflamed vs. excluded. b) Kaplan-Meier curve for survival of TCGA patients with a high or low TIL score. c-e) A/I ratio vs TIL score for the CPI treated patients separated by cancer type, coloured by response category. In the respective cancer types (BLCA: P = 0.003, LUNG: P = 0.15, SKCM: P = 0.006). (PDF)</p
<p>Kaplan-Meier curve for cancer-specific survival regarding high (≥2.3) versus low (<2.3) derived n...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...
Kaplan-Meier plots of the survival analysis of GC patient data: Kaplan-Meier plots of the survival a...
Kaplan-Meier curves showing the 15-year survival for each cancer type within the TCGA cohort, the pa...
Kaplan-Meier curves showing the 10-year survival for TCGA patients with an A/I score above the femal...
Kaplan-Meier curves showing the 15-year survival for each cancer type within the TCGA cohort, the pa...
The A/I ratio for 29 cancer types in the TCGA cohort. The cancertypes are ordered by median A/I rati...
Kaplan-Meier curves showing the five-year survival for each cancer type within the HMF cohort, the p...
a) Kaplan-Meier curve of 10,158 patients from the TCGA dataset. b) Kaplan-Meier curve of 1746 patien...
a) A forest plot showing the hazard ratio for progression of cancer for the expression of each of th...
a) A Kaplan-Meier curve showing the 15-year overall survival for patients in the TCGA cohort, the pa...
a) A/I ratio vs response to immunotherapy categories for the metastatic bladder cancer patients in t...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
The mean A/I ratio for 20 overlapping cancer types in the TCGA and HMF cohorts. The mean ratio of pr...
We considered cell type proportions estimated from the assayed expression levels in tumor tissues of...
<p>Kaplan-Meier curve for cancer-specific survival regarding high (≥2.3) versus low (<2.3) derived n...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...
Kaplan-Meier plots of the survival analysis of GC patient data: Kaplan-Meier plots of the survival a...
Kaplan-Meier curves showing the 15-year survival for each cancer type within the TCGA cohort, the pa...
Kaplan-Meier curves showing the 10-year survival for TCGA patients with an A/I score above the femal...
Kaplan-Meier curves showing the 15-year survival for each cancer type within the TCGA cohort, the pa...
The A/I ratio for 29 cancer types in the TCGA cohort. The cancertypes are ordered by median A/I rati...
Kaplan-Meier curves showing the five-year survival for each cancer type within the HMF cohort, the p...
a) Kaplan-Meier curve of 10,158 patients from the TCGA dataset. b) Kaplan-Meier curve of 1746 patien...
a) A forest plot showing the hazard ratio for progression of cancer for the expression of each of th...
a) A Kaplan-Meier curve showing the 15-year overall survival for patients in the TCGA cohort, the pa...
a) A/I ratio vs response to immunotherapy categories for the metastatic bladder cancer patients in t...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
The mean A/I ratio for 20 overlapping cancer types in the TCGA and HMF cohorts. The mean ratio of pr...
We considered cell type proportions estimated from the assayed expression levels in tumor tissues of...
<p>Kaplan-Meier curve for cancer-specific survival regarding high (≥2.3) versus low (<2.3) derived n...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...
Kaplan-Meier plots of the survival analysis of GC patient data: Kaplan-Meier plots of the survival a...